Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background</h3><p>Accurate and noninvasive detection of isocitrate dehydrogenase (IDH, including IDH1 and IDH2) status is clinically meaningful for molecular stratification of glioma, but remains challenging.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Purpose</h3><p>To establish a model for classifying IDH status in gliomas based on multiparametric MRI.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Study Type</h3><p>Retrospective, radiomics.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Population</h3><p>In all, 105 consecutive cases of grade II–IV glioma with 50 IDH1 or IDH2 mutant (IDHm) and 55 IDH wildtype (IDHw) were separated into a training cohort (<i>n =</i> 73) and a test cohort (<i>n =</i> 32). </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Field Strength/Sequence</h3><p>Contrast‐enhanced T<sub>1</sub>‐weighted (CE‐T<sub>1</sub>W), T<sub>2</sub>‐weighted (T<sub>2</sub>W), and arterial spin labeling (ASL) images were acquired at 3.0T. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Assessment</h3><p>Two doctors manually labeled the volume of interest (VOI) on CE‐T<sub>1</sub>W, then T<sub>2</sub>W and ASL were coregistered to CE‐T<sub>1</sub>W. A total of 851 radiomics features were extracted on each VOI of three sequences. From the training cohort, all radiomics features with age and gender were processed by the Mann–Whitney <i>U</i>‐test, Pearson test, and least absolute shrinkage and selection operator to obtain optimal feature groups to train support vector machine models. The accuracy and area under curve (AUC) of all models for classifying the IDH status were calculated on the test cohort. Two subtasks were performed to verify the efficiency of texture features and the Pearson test in IDH status classification, respectively. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Statistical Tests</h3><p>The permutation test with Bonferroni correction; chi‐square test.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>The accuracy and AUC of the classifier, which combines the features of all three sequences, achieved 0.823 and 0.770 (<i>P</i> < 0.05), respectively. The best model established by texture features only had an AUC of 0.819 and an accuracy of 0.761. The best model established without the Pearson test got an AUC of 0.747 and an accuracy of 0.719. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Data Conclusion</h3><p>IDH genotypes of glioma can be identified by radiomics features from multiparameter MRI. The Pearson test improved the performance of the IDH classification models.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Level of Evidence</h3><p>4</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Technical Efficacy Stage</h3><p>1</p></section>

Radiomics Strategy for Molecular Subtype Stratification of Lower-Grade Glioma: Detecting IDH and TP53 Mutations Based on Multimodal MRI.

Radiomics and Qualitative Features From Multiparametric MRI Predict Molecular Subtypes in Patients With Lower-Grade Glioma

Noninvasive Prediction of IDH1 Mutation and ATRX Expression Loss in Low‐Grade Gliomas Using Multiparametric MR Radiomic Features

Predicting IDH Mutation Status in Low-Grade Gliomas Based on Optimal Radiomic Features Combined with Multi-Sequence Magnetic Resonance Imaging

Using Radiomics Based on Multicenter Magnetic Resonance Images to Predict Isocitrate Dehydrogenase Mutation Status of Gliomas.

Prediction of the Molecular Subtype of IDH Mutation Combined with MGMT Promoter Methylation in Gliomas via Radiomics Based on Preoperative MRI

Predicting IDH mutation status as well as Ki-67 and p53 expression in high-grade gliomas using amide proton transfer-weighted and arterial spin labeling MRI

Predicting Isocitrate Dehydrogenase ( IDH) Mutation Status in Gliomas Using Multiparameter MRI Radiomics Features

IDH mutation assessment of glioma using texture features of multimodal MR images.

IDH mutation-specific radiomic signature in lower-grade gliomas.

Quantitative MRI-based Radiomics for Noninvasively Predicting Molecular Subtypes and Survival in Glioma Patients

Qualitative and Quantitative MRI Analysis in IDH1 Genotype Prediction of Lower-Grade Gliomas: A Machine Learning Approach.

Automated machine learning to predict the co-occurrence of isocitrate dehydrogenase mutations and O6 -methylguanine-DNA methyltransferase promoter methylation in patients with gliomas

Radiomics-Based Method for Predicting the Glioma Subtype as Defined by Tumor Grade, IDH Mutation, and 1p/19q Codeletion

Noninvasive Idh1 Mutation Estimation Based on A Quantitative Radiomics Approach for Grade Ii Glioma

Radiomics strategy for glioma grading using texture features from multiparametric MRI.

A nomogram strategy for identifying the subclassification of IDH mutation and ATRX expression loss in lower-grade gliomas

Predicting IDH subtype of grade 4 astrocytoma and glioblastoma from tumor radiomic patterns extracted from multiparametric magnetic resonance images using a machine learning approach

Sub-region based radiomics analysis for prediction of isocitrate dehydrogenase and telomerase reverse transcriptase promoter mutations in diffuse gliomas

MRI Radiomics-Based Molecular Subgrouping and Survival Prediction in Glioma Patients

A novel image signature-based radiomics method to achieve precise diagnosis and prognostic stratification of gliomas